Another study showed that combined treatment with CSF-1 antibodies and chemotherapeutic agents enhanced the sensitivity of breast cancer tumor cells to chemotherapy by reducing TAM recruitment to the tumor microenvironment and inhibiting the expression of multidrug resistance gene 1, chemoresistance genes and matrix metalloproteinases (97). The gene discussed is CSF1; the disease is neoplasm.